UnitedHealth Group ( UNH -1.61%) was the worst-performing stock in the S&P 500 last month. It plunged 26.6% to 52-week lows of $248.88 per share on May 15 after CEO Andrew Witty abruptly resigned and ...

A nonprofit backed by the DNA-testing firm's former CEO, Anne Wojcicki, bid $305 million to take control of the company.

Also this week, more than two dozen states sued 23andMe to challenge the sale of its customers’ private data. The states argue the company must obtain explicit consent from its ...

The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.

Several states have joined a lawsuit against 23andme. They say bankruptcy shouldn't allow the genetic testing company to sell ...

Welcome to the future, folks—where AI is regulated, genetic testing companies have more plot twists than a soap opera, and ...

Texas Attorney General Ken Paxton is looking to protect Texans' genetic data with action filed this week in ongoing 23andMe ...

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...

A.I. may push ad creatives from producing to consulting. At Cannes, Monks, a marketing technology agency, will showcase a new ...

Ah, New York. The city that never sleeps is now the city that never lets AI sleep soundly, either. In a world where AI is ...

The genetic testing company 23andMe is poised to be sold to a nonprofit run by the company's former chief executive Anne ...

TTAM will acquire substantially all of 23andMe’s assets for $305 million, including its Personal Genome Service and Research ...